Skip to Main Content

Paper Details

FOLFCIS Treatment and Genomic Correlates of Response in Advanced Anal Squamous Cell Cancer.
Clin Colorectal Cancer
13
2019
5-fluorouracil, Advanced Anal Squamous Cell Cancer, CDKN2A, CDKN2A mutations, FOLFCIS, FOLFOX, KMT2D, PATIENTS, PIK3CA, SCC, TERT promoter, TP53, advanced anal SCC, advanced anal squamous cell cancer, anal SCC, chromosome 3q, cisplatin, fluorouracil, human papillomavirus-negative anal SCC, leucovorin, oxaliplatin, patients, platinum
Author NameAffiliation
Walid K ChatilaMarie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center
Ritika KundraMarie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center
Nikolaus SchultzMarie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center
Nikolaus SchultzMarie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center
  • 1 - 4

Datasets

Release 1.2